Kingdon Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History
Bought
Maintained
Sold
Other funds holding MTEM
BG
BI
CC
PAMS
CS
Kingdon Capital Management's MTEM Position: Q4 2022 in Review
Kingdon Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2022, closing a stake of 35,207 shares — an estimated $396K sold.
Kingdon Capital Management first reported a position in MTEM in Q2 2013 and held it in 21 quarters. The position peaked at $12.1M in Q1 2021. 49 funds tracked by Wall St. Rank hold MTEM as of Q4 2022.
- Kingdon Capital Management reported no remaining Molecular Templates, Inc. position as of Q4 2022 after selling out during the quarter.
- Kingdon Capital Management sold 35,207 Molecular Templates, Inc. shares in Q4 2022, an estimated $396K.
- Kingdon Capital Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 21 quarters.
- Kingdon Capital Management's Molecular Templates, Inc. position peaked at $12.1M in Q1 2021.
- 49 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2022.
Based on Kingdon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.